Pricing

BELLUS Health Inc (BLU)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Roberto Bellini
Employees:
40
275 ARMAND-FRAPPIER BLVD., LAVAL, A8, H7V 4A7
450-680-4500
    Formally known as:
  • BELLUS HEALTH INC NEW COM SHS
  • BELLUS Health Inc.
  • Neurochem Inc.

Are you looking for this stock instead?

Stock Split History
DateRatio
2012-05-29 1:30
BELLUS Health Inc. develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available